• Regenerative Medical Technology Group filed a Form NT 10-Q, delaying its quarterly report for the period ended June 30, 2026.
• The company cited an inability to compile all information for the financial statements and related disclosures without unreasonable effort or expense.
• It expects to file the Form 10-Q within the five-calendar-day extension allowed under SEC Rule 12b-25.
• The notice indicated no anticipated significant change in results of operations versus the year-earlier period.
• The late-filing notice was signed Aug. 14, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-089586), on August 14, 2026, and is solely responsible for the information contained therein.